Pricing Log in Create free account

Kiora Pharmaceuticals, Inc. (KPRX) vs XTL Biopharmaceuticals Ltd. (XTLB)

Kiora Pharmaceuticals, Inc. and XTL Biopharmaceuticals Ltd. are both Biotechnology companies. Kiora Pharmaceuticals, Inc. and XTL Biopharmaceuticals Ltd. are of similar size ($7.3M and $6.6M). Kiora Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 983.7% against −12.7%. Across the 13 metrics below, Kiora Pharmaceuticals, Inc. leads on 7 and XTL Biopharmaceuticals Ltd. on 6.

Valuation

Metric KPRX XTLB Biotechnology median
P/E n/m n/m 10.26
P/S 0.49 1.19 9.18
P/B 0.55 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.59 n/m 0.65
EV/Sales (0.40) 1.10 8.98
Earnings yield (166.02%) (28.44%) (34.89%)
Free cash flow yield (93.58%) (158.67%) (24.52%)

Profitability

Metric KPRX XTLB Biotechnology median
Gross margin 85.06% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (56.36%) 0.00% (50.12%)
Return on assets (39.43%) 0.00% (45.60%)
Return on invested capital (44,053.91%) 0.00% 0.00%

Growth

Metric KPRX XTLB Biotechnology median
Revenue growth (TTM) 983.73% (12.71%) 6.26%
EPS growth (last fiscal year) (403.45%) (409.84%) 29.88%
Revenue growth, 5-year CAGR 88.72% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KPRX XTLB Biotechnology median
Debt to equity 0.00 (1.83) 0.00
Current ratio 8.97 0.70 4.89
Net debt to EBITDA 1.33 (0.11) 1.01

Dividend

Metric KPRX XTLB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KPRX XTLB Biotechnology median
Market cap 6.63m 7.25m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack